{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:07:07Z","timestamp":1765728427698},"publisher-location":"Boston, MA","reference-count":5,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461374565"},{"type":"electronic","value":"9781461553816"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998]]},"DOI":"10.1007\/978-1-4615-5381-6_3","type":"book-chapter","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T00:12:19Z","timestamp":1316218339000},"page":"13-18","source":"Crossref","is-referenced-by-count":83,"title":["Optimal Range of Serum Urate Concentrations to Minimize Risk of Gouty Attacks During Anti-Hyperuricemic Treatment"],"prefix":"10.1007","author":[{"given":"Hisashi","family":"Yamanaka","sequence":"first","affiliation":[]},{"given":"Riko","family":"Togashi","sequence":"additional","affiliation":[]},{"given":"Masayuki","family":"Hakoda","sequence":"additional","affiliation":[]},{"given":"Chihiro","family":"Terai","sequence":"additional","affiliation":[]},{"given":"Sadao","family":"Kashiwazaki","sequence":"additional","affiliation":[]},{"given":"Takashi","family":"Dan","sequence":"additional","affiliation":[]},{"given":"Naoyuki","family":"Kamatani","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0889-857X(21)00975-3","volume":"14","author":"SL Wallace","year":"1988","unstructured":"Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin North Am 14, 441\u2013457, 1988","journal-title":"Rheum Dis Clin North Am"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.1780170517","volume":"17","author":"HE Paulus","year":"1974","unstructured":"Paulus HE, Schlosstein LH, Godfrey RC, Klinenberg JR, Bluestone R:Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients. Arthritis Rheum 17, 609\u2013614, 1974","journal-title":"Arthritis Rheum"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5694\/j.1326-5377.1993.tb137784.x","volume":"159","author":"TV Kot","year":"1993","unstructured":"Kot TV, Day RO, Brooks PM:Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs? Med J Aust 159, 182\u2013184, 1993","journal-title":"Med J Aust"},{"key":"3_CR4","unstructured":"Terkeltaub RA:Pathogenesis and treatment of crystal induced inflammation. In, Arthritis and Allied Conditions. Twelfth edition. Edited by DJ McCarty, WJ Koopman. Philadelphia, Lea & Febiger, 1993"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu T-F:Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20, 895\u2013900, 1977","journal-title":"Arthritis Rheum"}],"container-title":["Advances in Experimental Medicine and Biology","Purine and Pyrimidine Metabolism in Man IX"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-5381-6_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T07:22:29Z","timestamp":1638688949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-5381-6_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"ISBN":["9781461374565","9781461553816"],"references-count":5,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-5381-6_3","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1998]]}}}